Cases & Deals

Jefferies finances AMAG Pharmaceuticals' acquisition of Cord Blood Registry®

Clients Jefferies Finance LLC and Jefferies LLC

Jones Day advised Jefferies Finance LLC, as administrative agent, collateral agent, joint lead arranger and joint bookrunner, and Jefferies LLC, as representative of the initial purchasers, in connection with the $850 million in financing provided to AMAG Pharmaceuticals, Inc., a specialty pharmaceutical company with a focus on maternal health, anemia, and cancer supportive care, to finance a portion of its acquisition of Cord Blood Registry® (CBR®), a large stem cell collection and storage company. The financing consisted of $500 million in aggregate principal amount of 7.875% Senior Notes due 2023 in a Rule 144A and Regulation S offering and a $350 million term loan.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.